▁Bre 10.375
ast 6.74609375
▁cancer 7.609375
▁is 6.703125
▁a 1.7890625
▁serious 3.29296875
▁health 2.4375
▁concern 2.71875
▁affect 6.32421875
ing 0.2308349609375
▁numerous 5.99609375
▁individuals 2.41015625
, 2.078125
▁particularly 5.1875
▁women 6.25390625
, 2.787109375
▁around 4.0390625
▁the 1.4365234375
▁world 2.162109375
. 2.4921875
▁It 2.90625
▁is 0.95556640625
▁cru 4.5
cial 0.037872314453125
▁to 1.1474609375
▁identify 4.9765625
▁and 3.55078125
▁understand 3.734375
▁the 0.7470703125
▁critical 5.83203125
▁factors 3.162109375
▁contrib 3.54296875
uting 0.004055023193359375
▁to 0.129638671875
▁its 5.296875
▁development 3.107421875
▁in 3.015625
▁order 2.609375
▁to 0.1104736328125
▁develop 4.453125
▁appropriate 2.6171875
▁prevent 3.47265625
ion 2.517578125
▁and 1.9306640625
▁treatment 1.837890625
▁strateg 0.7783203125
ies 0.003490447998046875
. 1.0146484375
▁Three 7.9296875
▁major 3.50390625
▁factors 1.611328125
▁influen 4.37890625
cing 0.0016584396362304688
▁the 1.072265625
▁development 1.3720703125
▁of 0.1392822265625
▁breast 1.416015625
▁cancer 0.0282135009765625
▁include 2.15625
▁her 4.48828125
ed 0.55078125
ity 0.056365966796875
, 0.1614990234375
▁dise 9.6015625
ases 0.01004791259765625
▁of 3.037109375
▁the 0.677734375
▁m 5.5703125
amm 0.05242919921875
ary 0.0005950927734375
▁g 0.309814453125
lands 1.2685546875
, 0.5556640625
▁and 0.206298828125
▁h 2.669921875
orm 0.0184478759765625
onal 0.171630859375
▁factors 1.2666015625
. 0.270263671875
<0x0A> 1.7724609375
H 2.41796875
ered 0.052764892578125
ity 0.002239227294921875
▁plays 2.375
▁a 0.361572265625
▁significant 1.80078125
▁role 0.045074462890625
▁in 0.0701904296875
▁breast 2.0234375
▁cancer 0.040313720703125
▁sus 5.21484375
cept 0.000377655029296875
ibility 0.0019359588623046875
. 0.79541015625
▁In 2.919921875
her 2.353515625
ited 0.018402099609375
▁gene 2.92578125
▁mut 0.453369140625
ations 0.0321044921875
, 2.556640625
▁such 1.5126953125
▁as 0.003398895263671875
▁BR 0.576171875
CA 0.0020236968994140625
1 0.301513671875
▁and 0.306396484375
▁BR 0.03668212890625
CA 0.0034275054931640625
2 0.01174163818359375
, 0.1781005859375
▁increase 2.626953125
▁the 0.361083984375
▁risk 0.2047119140625
▁of 0.158447265625
▁developing 0.9365234375
▁breast 0.32470703125
▁cancer 0.048736572265625
. 0.62353515625
▁Ind 5.5546875
ividual 0.01506805419921875
s 0.027130126953125
▁with 0.6337890625
▁a 0.9140625
▁strong 3.572265625
▁family 0.2237548828125
▁history 0.0084381103515625
▁of 0.1202392578125
▁the 4.109375
▁disease 0.042510986328125
▁are 1.0859375
▁more 1.43359375
▁likely 0.42529296875
▁to 0.01806640625
▁inherit 4.94140625
▁these 1.59765625
▁mut 0.595703125
ated 3.27734375
▁gen 0.1346435546875
es 0.002506256103515625
. 1.060546875
▁However 3.623046875
, 0.0029087066650390625
▁it 3.15234375
▁is 0.2666015625
▁important 1.173828125
▁to 0.041290283203125
▁note 0.5322265625
▁that 0.0142669677734375
▁her 3.9140625
edit 0.70458984375
ary 0.00030732154846191406
▁factors 1.5380859375
▁account 3.275390625
▁for 0.048614501953125
▁only 0.418212890625
▁a 1.001953125
▁small 0.28369140625
▁percentage 0.97119140625
▁of 0.02099609375
▁breast 0.763671875
▁cancer 0.2071533203125
▁cases 0.2337646484375
, 2.017578125
▁with 2.171875
▁the 1.263671875
▁majority 1.009765625
▁being 1.853515625
▁sp 3.28515625
or 0.1243896484375
adic 0.001979827880859375
. 0.9248046875
<0x0A> 0.82958984375
D 0.81884765625
ise 0.03228759765625
ases 0.01247406005859375
▁of 0.0199737548828125
▁the 0.0164947509765625
▁m 0.28857421875
amm 0.0015306472778320312
ary 0.0002827644348144531
▁g 0.004810333251953125
lands 0.05169677734375
, 2.859375
▁such 0.76611328125
▁as 0.003559112548828125
▁ben 4.7734375
ign 1.2278556823730469e-05
▁breast 0.81103515625
▁conditions 2.181640625
▁like 3.60546875
▁at 4.3515625
yp 0.451171875
ical 0.03399658203125
▁hyper 0.4482421875
pl 0.01222991943359375
asia 0.0164031982421875
▁or 2.35546875
▁lo 3.634765625
b 0.004779815673828125
ular 0.0032978057861328125
▁car 0.2347412109375
cin 0.0001462697982788086
oma 0.0020389556884765625
▁in 0.086181640625
▁situ 0.0198974609375
, 0.484375
▁also 3.271484375
▁contribute 1.2412109375
▁to 0.119140625
▁the 0.55810546875
▁development 0.2486572265625
▁of 0.014068603515625
▁breast 0.12152099609375
▁cancer 0.007480621337890625
. 0.0933837890625
▁These 1.45703125
▁conditions 0.87255859375
▁can 2.2265625
▁sometimes 4.71875
▁progress 2.333984375
▁to 0.264892578125
▁invas 0.90771484375
ive 0.00022351741790771484
▁breast 1.0712890625
▁cancer 0.11151123046875
▁if 3.09765625
▁left 0.6455078125
▁un 0.039154052734375
tre 0.031463623046875
ated 4.410743713378906e-05
. 0.24462890625
▁Additionally 3.513671875
, 0.0006737709045410156
▁other 3.638671875
▁risk 4.15625
▁factors 0.0015325546264648438
▁like 4.00390625
▁previous 6.8046875
▁radiation 2.8984375
▁ther 0.978515625
apy 0.00849151611328125
▁or 1.5380859375
▁certain 4.0546875
▁h 1.0439453125
orm 0.00011432170867919922
one 1.591796875
▁ther 1.4833984375
ap 0.080322265625
ies 3.3855438232421875e-05
▁can 0.85107421875
▁increase 0.57080078125
▁the 0.215576171875
▁lik 2.826171875
elihood 0.0008726119995117188
▁of 0.0157928466796875
▁m 5.828125
align 0.192138671875
ant 0.414794921875
▁transformation 0.76806640625
▁in 2.029296875
▁the 1.791015625
▁m 2.12109375
amm 0.003124237060546875
ary 0.0005221366882324219
▁g 0.074951171875
lands 0.213134765625
. 0.0771484375
<0x0A> 0.2181396484375
H 0.65087890625
orm 5.805492401123047e-05
onal 0.04388427734375
▁factors 0.019927978515625
▁are 1.6123046875
▁another 2.12890625
▁critical 3.80859375
▁contrib 1.7880859375
utor 0.69677734375
▁to 0.032470703125
▁breast 0.9775390625
▁cancer 0.0016279220581054688
. 1.9638671875
▁Est 3.177734375
ro 0.1939697265625
gen 3.0994415283203125e-05
▁expos 5.48828125
ure 0.0022735595703125
▁over 6.05859375
▁a 0.72412109375
▁long 0.43896484375
▁period 0.080810546875
▁of 0.06304931640625
▁time 0.000766754150390625
, 1.4560546875
▁either 3.0625
▁through 0.728515625
▁early 5.79296875
▁on 3.279296875
set 0.0163116455078125
▁of 0.74853515625
▁men 0.98046875
stru 1.3583984375
ation 0.031494140625
, 2.423828125
▁late 4.5078125
▁men 0.8583984375
op 0.1307373046875
ause 0.01319122314453125
, 0.1070556640625
▁or 0.1497802734375
▁h 2.412109375
orm 0.018157958984375
one 0.1492919921875
▁replacement 0.29736328125
▁ther 0.01337432861328125
apy 0.03070068359375
, 0.2354736328125
▁can 0.7109375
▁increase 0.68017578125
▁the 0.1807861328125
▁risk 0.05279541015625
▁of 0.0197601318359375
▁breast 1.078125
▁cancer 0.0103912353515625
. 0.309326171875
▁High 4.99609375
▁levels 1.2705078125
▁of 0.001995086669921875
▁est 0.6025390625
ro 0.06854248046875
gen 5.3763389587402344e-05
▁can 1.2021484375
▁promote 2.509765625
▁the 0.30908203125
▁growth 0.60302734375
▁of 0.24853515625
▁breast 1.3583984375
▁cells 2.046875
▁and 0.9619140625
▁potentially 5.43359375
▁lead 1.6298828125
▁to 0.0009527206420898438
▁the 1.349609375
▁development 0.10137939453125
▁of 0.00848388671875
▁cancer 1.533203125
ous 1.0849609375
▁cells 1.9541015625
. 0.1695556640625
<0x0A> 1.130859375
Det 7.35546875
ect 1.3583984375
ing 0.028411865234375
▁early 3.3515625
▁met 10.1484375
ast 0.0290985107421875
asis 1.96484375
▁is 1.890625
▁vital 3.44140625
▁for 1.3427734375
▁effective 2.59375
▁breast 2.00390625
▁cancer 0.0025615692138671875
▁treatment 0.10552978515625
. 0.28759765625
▁Met 3.25390625
ast 0.00354766845703125
asis 0.287353515625
▁occurs 1.439453125
▁when 0.03204345703125
▁cancer 0.284912109375
▁cells 0.1473388671875
▁spread 0.7216796875
▁to 1.087890625
▁other 0.2117919921875
▁parts 0.748046875
▁of 0.0004611015319824219
▁the 0.001613616943359375
▁body 0.004070281982421875
, 0.73388671875
▁making 5.59375
▁treatment 3.22265625
▁more 0.62841796875
▁challeng 1.2646484375
ing 2.0623207092285156e-05
. 0.52978515625
▁Early 1.2978515625
▁detection 0.1435546875
▁of 1.05078125
▁met 0.67724609375
ast 0.00012695789337158203
asis 0.2193603515625
▁enables 4.359375
▁health 4.62890625
care 0.2093505859375
▁profession 0.86328125
als 7.152557373046875e-07
▁to 0.004669189453125
▁plan 5.24609375
▁appropriate 2.91015625
▁inter 4.03515625
vent 0.1632080078125
ions 0.00159454345703125
▁and 1.15234375
▁strateg 6.01953125
ies 0.01114654541015625
▁to 1.0712890625
▁reduce 2.212890625
▁its 4.60546875
▁impact 1.7255859375
▁on 0.947265625
▁overall 3.40234375
▁outcome 6.5859375
▁and 3.390625
▁surv 1.2705078125
ival 0.0074920654296875
▁rates 1.169921875
. 0.037200927734375
<0x0A> 0.53662109375
To 4.6328125
▁determine 3.830078125
▁the 0.9697265625
▁ag 6.765625
gress 0.00630950927734375
iveness 0.0416259765625
▁of 0.07196044921875
▁breast 0.57958984375
▁cancer 0.0274658203125
, 0.1812744140625
▁health 3.994140625
care 0.06915283203125
▁profession 0.11138916015625
als 2.2649765014648438e-06
▁employ 5.15625
▁various 1.6025390625
▁methods 2.650390625
. 1.634765625
▁These 1.48828125
▁include 0.354248046875
▁tum 2.65234375
or 0.037017822265625
▁size 1.328125
▁and 2.109375
▁stage 3.162109375
, 0.57421875
▁grade 3.63671875
▁( 3.8515625
d 4.83203125
iffer 1.2451171875
enti 0.1146240234375
ation 0.3017578125
▁of 1.47265625
▁cancer 1.4736328125
▁cells 0.288330078125
), 1.748046875
▁l 2.71484375
ym 0.0027332305908203125
ph 5.841255187988281e-05
▁node 0.172607421875
▁invol 0.6611328125
vement 0.0027675628662109375
, 0.0701904296875
▁and 0.361328125
▁the 2.265625
▁presence 0.869140625
▁of 0.0706787109375
▁specific 4.14453125
▁bi 3.615234375
om 0.034759521484375
ark 0.0022068023681640625
ers 0.0226287841796875
▁like 2.763671875
▁human 3.021484375
▁e 0.044403076171875
pid 0.0011472702026367188
erm 0.06390380859375
al 0.0005955696105957031
▁growth 0.0065765380859375
▁factor 0.01201629638671875
▁re 0.0889892578125
ceptor 0.04022216796875
▁ 0.1475830078125
2 0.0016880035400390625
▁( 0.20068359375
HER 0.024322509765625
2 0.08428955078125
) 0.94140625
▁or 1.443359375
▁h 5.28515625
orm 0.056121826171875
one 0.0692138671875
▁re 0.0227813720703125
cept 0.40771484375
ors 0.0005793571472167969
▁( 1.6142578125
estro 1.7138671875
gen 0.00014519691467285156
▁or 2.345703125
▁pro 0.0251007080078125
g 0.00424957275390625
ester 0.0002799034118652344
one 0.0004725456237792969
). 0.70556640625
▁These 2.576171875
▁factors 1.29296875
▁help 1.7119140625
▁to 1.6650390625
▁determine 1.1015625
▁treatment 3.65625
▁options 0.57080078125
, 1.275390625
▁such 1.32421875
▁as 0.005970001220703125
▁surg 1.107421875
ery 0.2196044921875
, 0.22998046875
▁chem 0.75439453125
other 0.01378631591796875
apy 0.0019378662109375
, 0.032012939453125
▁radiation 2.21875
▁ther 0.26171875
apy 0.004146575927734375
, 0.0168914794921875
▁or 0.6884765625
▁target 1.712890625
ed 0.00445556640625
▁ther 0.1607666015625
ap 0.7412109375
ies 1.3113021850585938e-05
. 0.286376953125
<0x0A> 0.1632080078125
In 3.080078125
▁conclusion 1.0673828125
, 0.0009465217590332031
▁understanding 4.9453125
▁the 0.164306640625
▁critical 2.255859375
▁factors 0.06732177734375
▁contrib 0.6240234375
uting 8.499622344970703e-05
▁to 0.0011129379272460938
▁breast 1.4892578125
▁cancer 0.0006818771362304688
▁development 0.91650390625
, 3.91796875
▁such 1.876953125
▁as 0.002986907958984375
▁her 0.266845703125
ed 0.093505859375
ity 0.0001881122589111328
, 0.0396728515625
▁dise 0.5
ases 0.00016236305236816406
▁of 0.01195526123046875
▁the 0.008148193359375
▁m 0.002105712890625
amm 0.0007648468017578125
ary 6.92605972290039e-05
▁g 0.0010528564453125
lands 0.01202392578125
, 0.027740478515625
▁and 0.11395263671875
▁h 0.0184173583984375
orm 5.960464477539062e-07
onal 0.016876220703125
▁factors 0.0030231475830078125
, 0.053192138671875
▁is 0.41650390625
▁cru 1.63671875
cial 0.00020825862884521484
▁in 2.92578125
▁prevent 3.244140625
ing 0.1517333984375
▁its 2.892578125
▁occurrence 2.96484375
▁and 0.6220703125
▁impro 3.236328125
ving 0.00039267539978027344
▁treatment 1.56640625
▁out 0.360595703125
comes 0.00021970272064208984
. 0.0418701171875
▁Early 2.716796875
▁detection 0.08258056640625
▁of 0.54296875
▁met 0.240478515625
ast 2.8014183044433594e-05
asis 0.03515625
▁is 1.1025390625
▁essential 2.10546875
▁for 0.38525390625
▁effective 0.480712890625
▁treatment 0.94482421875
▁planning 4.46484375
, 1.96484375
▁while 3.16796875
▁determ 5.60546875
ining 0.0054473876953125
▁the 0.283935546875
▁ag 0.1895751953125
gress 0.0004589557647705078
iveness 0.0012388229370117188
▁of 0.0288848876953125
▁breast 0.5263671875
▁cancer 0.006359100341796875
▁a 7.42578125
ids 0.041259765625
▁in 0.142822265625
▁choosing 2.29296875
▁appropriate 2.0390625
▁treatment 0.36669921875
▁strateg 2.06640625
ies 2.5033950805664062e-06
. 0.16796875
▁Health 3.833984375
▁aw 9.7265625
aren 0.00011432170867919922
ess 2.300739288330078e-05
▁campaign 1.8740234375
s 0.0010423660278320312
, 1.6787109375
▁gen 6.9296875
etic 0.035888671875
▁testing 1.380859375
, 0.155029296875
▁and 0.1470947265625
▁regular 3.37109375
▁screen 0.8544921875
ings 0.5361328125
▁are 0.73779296875
▁essential 2.263671875
▁in 0.80322265625
▁address 5.1328125
ing 9.012222290039062e-05
▁breast 1.87109375
▁cancer 0.0067138671875
▁and 2.0625
▁reducing 2.35546875
▁its 0.3173828125
▁impact 0.83251953125
▁on 0.252197265625
▁individuals 2.7890625
▁and 1.0556640625
▁communities 1.74609375
. 0.234619140625
